Skip to main content

Table 4 Demographic details of asthma patients

From: Prevalence of gastro-oesophageal reflux disease symptoms and reflux-associated respiratory symptoms in asthma

  Asthmatics with GORD score
> 12.5 (n = 120)
Asthmatics with GORD score
<12.5 (n = 82)
P value
Age, yrs; mean (SD) 34.4 (11.4) 35.6 (11.8) 0.318
Males/females 53/67 36/46 1.000
BMI, kg/m2; mean (SD) 21.9 (3.3) 22.6 (2.5) 0.126
Current smoker (% of subjects) 13.3 11.0 0.630
Current drinker (% of subjects) 20.0 7.3 0.040*
Asthma severity (% of subjects)    
   Mild intermittent 66.7 89.0 0.001
   Mild persistent 22.5 9.8  
   Moderate or severe persistent 10.8 1.2  
Asthma medication (% of subjects)    
   Oral salbutamol 68.3 50.0 0.009*
   Inhaled salbutamol 53.3 62.2 0.212
   Oral theophylline 33.3 28.0 0.426
   Oral steroids 18.3 9.8 0.092
   Inhaled steroids 40.0 34.1 0.399
  1. * Chi squared test